The immune system is a major target for cancer treatments. Immune checkpoint inhibitors and CAR-T cell therapy can dramatically improve outcomes for many cancers. But for about 70% of patients, these therapies don’t work.
M&A: Avel eCare acquires Horizon Virtual
What You Should Know: – Avel eCare, the nation’s leading provider of clinician-to-clinician telemedicine services, continues its aggressive growth strategy with the acquisition of Horizon
May 2, 2024